Total results2,176
Search criteria
All records
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| ITAL | P20701 | Integrin alpha-L (CD11 antigen-like family member A) (Leukocyte adhesion glycoprotein LFA-1 alpha chain) (LFA-1A) (Leukocyte function-associated molecule 1 alpha chain) (CD antigen CD11a) | CD markersFDA approved drug targetsPredicted intracellular proteins | 1 | Conjunctiva disorderDiabetes mellitusHuman immunodeficiency virus disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| ITB1 | P05556 | Integrin beta-1 (Fibronectin receptor subunit beta) (Glycoprotein IIa) (GPIIA) (VLA-4 subunit beta) (CD antigen CD29) | Cancer-related genesCD markersFDA approved drug targets | 1 | Brain cancerLung cancerRetinopathy | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| ITB6 | P18564 | Integrin beta-6 | Cancer-related genesDisease related genesHuman disease related genes | 1 | Amelogenesis imperfectaSolid tumour/cancer | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 3 | 0.53 | ||
| JAK3 | P52333 | Tyrosine-protein kinase JAK3 (EC 2.7.10.2) (Janus kinase 3) (JAK-3) (Leukocyte janus kinase) (L-JAK) | Cancer-related genesDisease related genesEnzymes | SCID | Adhesion and uptake mediationClinical-translation mediationImmune mediation | 3 | 0.53 | |||
| KCC2B | Q13554 | Calcium/calmodulin-dependent protein kinase type II subunit beta (CaM kinase II subunit beta) (CaMK-II subunit beta) (EC 2.7.11.17) | Disease related genesEnzymesHuman disease related genes | Intellectual disability | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 3 | 0.53 | |||
| KCNV1 | Q6PIU1 | Potassium voltage-gated channel subfamily V member 1 (Neuronal potassium channel alpha subunit HNKA) (Voltage-gated potassium channel subunit Kv8.1) | 6 | Fusion and delivery mediation | 3 | 0.53 | ||||
| KI2L3 | P43628 | Killer cell immunoglobulin-like receptor 2DL3 (CD158 antigen-like family member B2) (KIR-023GB) (Killer inhibitory receptor cl 2-3) (NKAT2a) (NKAT2b) (Natural killer-associated transcript 2) (NKAT-2) (p58 natural killer cell receptor clone CL-6) (p58 NK receptor CL-6) (p58.2 MHC class-I-specific NK receptor) (CD antigen CD158b2) | 1 | Immune mediation | 3 | 0.53 | ||||
| KLD7B | Q96G42 | Kelch domain-containing protein 7B | Predicted intracellular proteins | Other mediation | 3 | 0.53 | ||||
| LDLR | P01130 | Low-density lipoprotein receptor (LDL receptor) | Disease related genesHuman disease related genesMetabolic proteins | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 3 | 0.53 | |||
| LENG1 | Q96BZ8 | Leukocyte receptor cluster member 1 | Essential proteinsPredicted intracellular proteins | Other mediation | 3 | 0.53 |